365 related articles for article (PubMed ID: 9635664)
1. Treatment of refractory intracranial hypertension with 23.4% saline.
Suarez JI; Qureshi AI; Bhardwaj A; Williams MA; Schnitzer MS; Mirski M; Hanley DF; Ulatowski JA
Crit Care Med; 1998 Jun; 26(6):1118-22. PubMed ID: 9635664
[TBL] [Abstract][Full Text] [Related]
2. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline.
Qureshi AI; Wilson DA; Traystman RJ
Neurosurgery; 1999 May; 44(5):1055-63; discussion 1063-4. PubMed ID: 10232539
[TBL] [Abstract][Full Text] [Related]
3. Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury.
Huang X; Yang L; Ye J; He S; Wang B
Medicine (Baltimore); 2020 Sep; 99(38):e22004. PubMed ID: 32957318
[TBL] [Abstract][Full Text] [Related]
4. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury.
Khanna S; Davis D; Peterson B; Fisher B; Tung H; O'Quigley J; Deutsch R
Crit Care Med; 2000 Apr; 28(4):1144-51. PubMed ID: 10809296
[TBL] [Abstract][Full Text] [Related]
5. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.
Mangat HS; Chiu YL; Gerber LM; Alimi M; Ghajar J; Härtl R
J Neurosurg; 2015 Jan; 122(1):202-10. PubMed ID: 25380107
[TBL] [Abstract][Full Text] [Related]
6. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension.
Oddo M; Levine JM; Frangos S; Carrera E; Maloney-Wilensky E; Pascual JL; Kofke WA; Mayer SA; LeRoux PD
J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):916-20. PubMed ID: 19293171
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries.
Sakellaridis N; Pavlou E; Karatzas S; Chroni D; Vlachos K; Chatzopoulos K; Dimopoulou E; Kelesis C; Karaouli V
J Neurosurg; 2011 Feb; 114(2):545-8. PubMed ID: 21087203
[TBL] [Abstract][Full Text] [Related]
8. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
Kerwin AJ; Schinco MA; Tepas JJ; Renfro WH; Vitarbo EA; Muehlberger M
J Trauma; 2009 Aug; 67(2):277-82. PubMed ID: 19667879
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of refractory intracranial hypertension after traumatic brain injury with repeated boluses of 14.6% hypertonic saline.
Eskandari R; Filtz MR; Davis GE; Hoesch RE
J Neurosurg; 2013 Aug; 119(2):338-46. PubMed ID: 23706055
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Intracranial Pressure Measurements Before and After Hypertonic Saline or Mannitol Treatment in Children With Severe Traumatic Brain Injury.
Kochanek PM; Adelson PD; Rosario BL; Hutchison J; Miller Ferguson N; Ferrazzano P; O'Brien N; Beca J; Sarnaik A; LaRovere K; Bennett TD; Deep A; Gupta D; Willyerd FA; Gao S; Wisniewski SR; Bell MJ;
JAMA Netw Open; 2022 Mar; 5(3):e220891. PubMed ID: 35267036
[TBL] [Abstract][Full Text] [Related]
11. A pilot study evaluating the effect of mannitol and hypertonic saline solution in the treatment of increased intracranial pressure in 2 cats and 1 dog naturally affected by traumatic brain injury.
Ballocco I; Evangelisti MA; Deiana R; Cubeddu F; Pinna Parpaglia ML; Serra G; Carta G; Manunta ML
J Vet Emerg Crit Care (San Antonio); 2019 Sep; 29(5):578-584. PubMed ID: 31448527
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Study of Bolus Dose of Hypertonic Saline, Mannitol, and Mannitol Plus Glycerol Combination in Patients with Severe Traumatic Brain Injury.
Patil H; Gupta R
World Neurosurg; 2019 May; 125():e221-e228. PubMed ID: 30684710
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 3% Hypertonic Saline and 20% Mannitol for Reducing Intracranial Pressure in Patients Undergoing Supratentorial Brain Tumor Surgery: A Randomized, Double-blind Clinical Trial.
Ali A; Tetik A; Sabanci PA; Altun D; Sivrikoz N; Abdullah T; Aydoseli A; Sencer A; Akinci IO
J Neurosurg Anesthesiol; 2018 Apr; 30(2):171-178. PubMed ID: 28763434
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke.
Schwarz S; Schwab S; Bertram M; Aschoff A; Hacke W
Stroke; 1998 Aug; 29(8):1550-5. PubMed ID: 9707191
[TBL] [Abstract][Full Text] [Related]
15. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension?
Infanti JL
J Neurosci Nurs; 2008 Dec; 40(6):362-8. PubMed ID: 19170304
[TBL] [Abstract][Full Text] [Related]
16. The impact of hypertonic saline on cerebrovascular reactivity and compensatory reserve in traumatic brain injury: an exploratory analysis.
Froese L; Dian J; Batson C; Gomez A; Unger B; Zeiler FA
Acta Neurochir (Wien); 2020 Nov; 162(11):2683-2693. PubMed ID: 32959342
[TBL] [Abstract][Full Text] [Related]
17. Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen.
Rockswold GL; Solid CA; Paredes-Andrade E; Rockswold SB; Jancik JT; Quickel RR
Neurosurgery; 2009 Dec; 65(6):1035-41; discussion 1041-2. PubMed ID: 19934962
[TBL] [Abstract][Full Text] [Related]
18. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage.
Bentsen G; Breivik H; Lundar T; Stubhaug A
Crit Care Med; 2006 Dec; 34(12):2912-7. PubMed ID: 17075367
[TBL] [Abstract][Full Text] [Related]
19. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study.
Ware ML; Nemani VM; Meeker M; Lee C; Morabito DJ; Manley GT
Neurosurgery; 2005 Oct; 57(4):727-36; discussion 727-36. PubMed ID: 16239885
[TBL] [Abstract][Full Text] [Related]
20. Comparison of equiosmolar doses of 10% hypertonic saline and 20% mannitol for controlling intracranial hypertention in patients with large hemispheric infarction.
Su Y; Liu Y; Chen Z; Cui L
Clin Neurol Neurosurg; 2021 Jan; 200():106359. PubMed ID: 33246252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
